8-KEarnings & ResultsExhibits & Filings

AMGEN INC 8-K Report, Financial Results (Oct 27, 2014)

Filed October 27, 2014For Securities:AMGN

Summary

This 8-K filing by Amgen Inc. (AMGN) on October 27, 2014, primarily serves to report the company's unaudited financial results for the three and nine months ended September 30, 2014. The filing indicates that a press release detailing these results, along with the company's financial position as of September 30, 2014, was issued on the same day. Investors should note that the accompanying press release includes non-GAAP financial measures, such as adjusted earnings per share and free cash flow. Amgen's management provides explanations within the press release for why these non-GAAP measures are considered useful for investors and how they are used internally. Reconciliations between these non-GAAP figures and their most comparable GAAP counterparts are also provided in the press release.

Key Highlights

  • 1Amgen announced its unaudited financial results for the third quarter and the first nine months of 2014.
  • 2The report includes the company's unaudited financial position as of September 30, 2014.
  • 3A press release detailing the financial results was issued on October 27, 2014.
  • 4The press release contains non-U.S. Generally Accepted Accounting Principles (GAAP) financial measures.
  • 5Key non-GAAP measures mentioned include adjusted earnings per share, free cash flow, adjusted operating income, and adjusted tax rate.
  • 6Amgen's management explains the rationale for presenting non-GAAP measures and their utility to investors.
  • 7Reconciliations between non-GAAP and GAAP financial measures are included in the press release.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report Amgen's unaudited financial results for the third quarter and the first nine months of 2014, as well as its financial position as of September 30, 2014. It also formally includes the press release that announced these results.

The press release includes both U.S. GAAP financial measures and several non-GAAP financial measures. Notable non-GAAP measures mentioned are adjusted earnings per share, free cash flow, adjusted operating income, adjusted operating margin, adjusted tax rate, adjusted net income, and various adjusted operating expense components.

Amgen's management presents non-GAAP financial measures because they believe these metrics offer useful information to investors about the company's financial condition and operating results. These measures are also used internally by management for performance assessment and decision-making. Reconciliations to comparable GAAP measures are provided for clarity.

This filing and the information within the press release are generally not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor are they automatically incorporated by reference into future SEC filings unless specifically stated otherwise in those future filings. This means the information is primarily for informational purposes related to the specific reporting period.